AdHCPs: Review Complete Biomarker Results Before Developing A Plan For Patients With mNSCLC. Look Beyond PD-L1 For Biomarkers Of Interest When Evaluating mNSCLC Patients. Read More.
AdHCPs: View Mechanism Of Action For A Unresectable Hepatocellular Carcinoma Treatment. See If Combination Therapy For Unresectable HCC Is An Option For First-Line Treatment.
AdHEK293 recombinant expression. Quality control each batch. Suitable for ELISA/SPR/BLI/IMM. Purity verified by SDS-PAGE/SEC-MALS. Bioactivity verified by ELISA/CELL BASE assay.